Circulating aggregated platelets in coronary artery disease

Jacob Fuchs, Itzhak Weinberger, Zvi Rotenberg, Henry Joshua, Avi Almozlino, Jacob Agmon

Research output: Contribution to journalArticlepeer-review


Circulating aggregated platelets were assessed in 30 patients with stable angina, 22 with unstable angina and 50 with acute myocardial infarction (AMI). Fifty healthy volunteers and 20 noncardiac patients served as controls. One milliliter of venous blood was separated into 2 solutions: 1 composed of ethylenediamine tetraacetic acid (EDTA) and formalin containing reversible and irreversible aggregates and 1 composed of EDTA alone containing irreversible aggregates only. By direct microscopic readings the percentage of platelets forming aggregates/ 1,000 counted platelets was determined in the 2 solutions. The number of reversibly aggregated platelets was estimated by subtracting the percentage of aggregated platelets in the second solution from that in the first solution. In patients with stable angina the percentage of aggregated platelets was higher than in control subjects (15 ± 4% vs 7 ± 2%, p < 0.001). Most aggregated platelets (72% and 76%, respectively) were irreversibly aggregated. In the unstable angina group the percentage of aggregated platelets was similar to that of the AMI group (24 ± 13% and 24 ± 10%) and significantly higher than in the stable angina group. Only 11% and 17% of aggregated platelets in patients with stable angina and AMI were irreversibly aggregated and 89% and 83% of them were reversibly aggregated. Participation of platelets in the pathogenesis of unstable angina and AMI may be related to the early reversible phase of platelet activation.

Original languageEnglish
Pages (from-to)534-537
Number of pages4
JournalAmerican Journal of Cardiology
Issue number7
StatePublished - 1 Sep 1987


Dive into the research topics of 'Circulating aggregated platelets in coronary artery disease'. Together they form a unique fingerprint.

Cite this